Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher Terranova, Kunal Rai, Mayinuer Maitituoheti et al.|Cell Reports|2021Cited by 31